Clinical Trial

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.
Trial Details
NCT Number NCT06775821
Lead Sponsor First Affiliated Hospital of Kunming Medical University
Collaborators: The Third Affiliated Hospital of Kunming Medical University, Kunming Medical University
Conditions Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence
Enrollment 2,000 participants
Start Date 2022-10-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-15